A Randomized Placebo-Controlled Trial of Sarilumab in Hospitalized Patients with Covid-19
S. Sivapalasingam,D. Lederer, R. Bhore,N. Hajizadeh,G. Criner, R. Hossain,A. Mahmood, A. Giannelou,S. Somersan-Karakaya,M. O'Brien,A. Boyapati,J. Parrino, B. Musser, E. Labriola-Tompkins,D. Ramesh,L. Purcell, D. Gulabani, W. Kampman, A. Waldron, M. Ng Gong, S. Saggar, S. Sperber, V. Menon, D. Stein,M. Sobieszczyk, W. Park,J. Aberg,S. Brown,J. Kosmicki, J. Horowitz,M. Ferreira, A. Baras,B. Kowal,A. T. DiCioccio,B. Akinlade, M. Nivens,N. Braunstein, G. Herman, G. Yancopoulos,D. Weinreich, Sarilumab-COVID- Study Team medRxiv（2021）
Key words
sarilumab,hospitalized patients,placebo-controlled
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper